Colonic α-synuclein: A potential diagnostic biomarker in Parkinson’s disease
Objective: To validate detection of α-synuclein pathology in the gastrointestinal (GI) tract as a diagnostic marker of Parkinson's disease (PD). Background: α-synuclein (ASN) deposition in…CSF level of chromogranin A in amyotrophic lateral sclerosis
Objective: Today the diagnosis of amyotrophic lateral sclerosis (ALS) is based on clinical assessment of upper and lower motor neuron signs in the limb and/or…Osmotic demyelination syndrome with dystonia and parkinsonism responsive to dopaminergic therapy
Objective: To present a case of delayed-onset dystonia and parkinsonism secondary to osmotic demyelination syndrome, with dramatic response to pramipexole 3mg per day. Background: Osmotic…Factors affecting the cardiac sympathetic denervation in autopsy confirmed dementia with Lewy bodies
Objective: To examine the relation among degeneration of the cardiac sympathetic nerve (CSN), clinical features and neuropathological findings in dementia with Lewy bodies (DLB). Background:…Coupling between visual information and body sway in people with Parkinson’s disease
Objective: Investigate postural control performance and the coupling between visual information and body sway in people with Parkinson's disease (PD). Background: PD causes several changes…The effect of improved nutritional status on psychiatric features and quality of life in Parkinson’s disease patients
Objective: To determine the effect of nutritional status in 6 weeks time on depression, anxiety and quality of life in Parkinson's disease (PD) patients. Background:…Long-latency somatosensory evoked potentials of the subthalamic nucleus
Objective: This study aims to clarify the role of the STN, previously suggested as an integrative component in the control of the basal ganglia-thalamocortical circuit,…Prevalence of orthostatic hypotension after a low subacute levodopa dose in patients with parkinsonism
Objective: To evaluate the prevalence of orthostatic hypotension (OH) after a low subacute levodopa (LD) dose in patients with diagnosis of Parkinson's disease (PD) or…EEG Spectral power changes prior to non-epileptic seizures: A pilot study
Objective: To assess possible EEG spectral power changes prior to psychogenic non-epileptic seizures (PNES) and identify whether a “positive marker” of PNES may exist. Background:…Loss of heart rate variability in ALS: Time and frequency domain assessment
Objective: The aim of this study was to investigate alterations in cardiac autonomic control during sleep in patients affected by ALS. Background: Amyotrophic lateral sclerosis…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.